FCER2 and B-cell chronic lymphocytic leukemia: In addition, aCLL patients demonstrated a higher expression of CD23, but no significant difference was noted between aCLL and classic CLL regarding the expression of surface immunoglobulin (sIg), CD79b, or CD5.